Skip to Main Content

Paper Details

Activation of NF-κB and p300/CBP potentiates cancer chemoimmunotherapy through induction of MHC-I antigen presentation.
Proc Natl Acad Sci U S A
49
2021
AgPP, CBP, CD8, CREB binding protein, CTLs, IFN, MHC-, MHC-I, MHC-I AgPP, MHC-I AgPPM, MHC-I antigen, NF-B, PD-(L)1, PD-1, PD-L1, T-cell, cancer, cancers, cytotoxic T cells, human, lysine, major histocompatibility class I, mitoxantrone, nuclear factor kappa B, oxaliplatin, p300, platinoid, topoisomerase, tumor, tumors
Author NameAffiliation
Michelle DowUniversity of California San Diego
Michelle DowUniversity of California San Diego
Mark H EllismanNational Center for Microscopy and Imaging Research, Center for Research in Biological Systems, University of California San Diego
Mark H EllismanNational Center for Microscopy and Imaging Research, Center for Research in Biological Systems, University of California San Diego
Marcus BosenbergYale School of Medicine
Marcus BosenbergYale School of Medicine
Johannes HaybaeckInstitute of Pathology, Medical University of Graz
Johannes HaybaeckMedical University of Innsbruck
Kathleen M FischCenter for Computational Biology and Bioinformatics, University of California San Diego
Kathleen M FischCenter for Computational Biology and Bioinformatics, University of California San Diego
Hannah CarterUniversity of California San Diego
Hannah CarterUniversity of California San Diego
Hannah CarterUniversity of California San Diego
Hannah CarterUniversity of California San Diego
Ira MellmanInc.
Michael KarinUniversity of California San Diego
Michael KarinUniversity of California San Diego
  • 1 - 17

Datasets

Release 1.2